Workflow
百诚医药(301096.SZ)发布上半年业绩,归母净利润309.82万元,下降97.69%
Bio-SBio-S(SZ:301096) 智通财经网·2025-08-26 14:53

Group 1 - The core viewpoint of the article highlights that Baicheng Pharmaceutical (301096.SZ) reported a significant decline in both revenue and net profit for the first half of 2025 [1] Group 2 - The company's operating revenue for the first half of 2025 was 332 million yuan, representing a year-on-year decrease of 36.70% [1] - The net profit attributable to shareholders of the listed company was 3.0982 million yuan, showing a year-on-year decrease of 97.69% [1] - The net loss attributable to shareholders after deducting non-recurring gains and losses was 11.7301 million yuan [1] - The basic earnings per share were reported at 0.03 yuan [1]